Janet Hammond - Chief Development Officer at Atea Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Development Officer
Stock Symbol
AVIR on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Janet Hammond - trading volume in the past year for Atea Pharmaceuticals, Inc.

Holdings reported by Janet Hammond for Atea Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 93.6K $483K $5.16 Jan 31, 2024 Direct Common Stock
Common Stock 35.4K $136K $3.84 Feb 1, 2024 Direct
Stock Option (Right to Buy) 225K Jan 31, 2024 Direct Common Stock

Transactions reported by Janet Hammond for Atea Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.